牛叉诊股

[{"date":"2026.04.27","stock":"-1.21","trade":"-0.06","ind":"0.37"},{"date":"2026.04.24","stock":"4.98","trade":"0.07","ind":"-0.69"},{"date":"2026.04.23","stock":"-2.78","trade":"-1.89","ind":"-0.88"},{"date":"2026.04.22","stock":"-1.02","trade":"1.12","ind":"1.30"},{"date":"2026.04.21","stock":"1.77","trade":"-1.11","ind":"0.10"},{"date":"2026.04.20","stock":"-1.73","trade":"0.69","ind":"0.55"},{"date":"2026.04.17","stock":"-0.81","trade":"-1.80","ind":"0.60"},{"date":"2026.04.16","stock":"-1.79","trade":"-0.04","ind":"2.05"},{"date":"2026.04.15","stock":"-0.10","trade":"0.14","ind":"-0.97"},{"date":"2026.04.14","stock":"-0.30","trade":"1.73","ind":"1.61"},{"date":"2026.04.13","stock":"2.02","trade":"-1.22","ind":"0.69"},{"date":"2026.04.10","stock":"-1.00","trade":"0.70","ind":"2.24"},{"date":"2026.04.09","stock":"0.40","trade":"-1.86","ind":"-0.33"},{"date":"2026.04.08","stock":"1.63","trade":"2.51","ind":"4.79"},{"date":"2026.04.07","stock":"0.10","trade":"0.66","ind":"0.36"},{"date":"2026.04.03","stock":"-3.36","trade":"-3.06","ind":"-0.99"},{"date":"2026.04.02","stock":"0.50","trade":"-0.64","ind":"-1.60"},{"date":"2026.04.01","stock":"0.20","trade":"5.25","ind":"1.70"},{"date":"2026.03.31","stock":"-0.79","trade":"0.22","ind":"-1.81"},{"date":"2026.03.30","stock":"0.70","trade":"1.19","ind":"-0.25"},{"date":"2026.03.27","stock":"2.65","trade":"4.12","ind":"1.13"}]

*ST生物,深证成指,医疗服务指数

压力支撑

该股压力位为9.91元，支撑位为9.58元。

[{"text":"\u538b\u529b\u4f4d","value":"9.91","date":1777219200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"9.58","date":1777219200,"color":"0x0b52a1"}]

多空趋势

空头行情中，目前正处于反弹阶段，投资者可适当关注。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：3.5资金面打败了30%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

医疗服务行业，近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。

更新时间：04月28日 12:30

机构今日流向(万元)	-1042.95	机构5日流向(万元)	-4874.33
机构10日流向(万元)	-8377.55	机构20日流向(万元)	-11366.26

机构持仓

2025-06-30 与 2024-12-31 相比，主力机构持仓量减少306.86万股，其中基金数没有增加，主力净减仓3家，请投资者中长期谨慎为宜。

截止2025-06-30，共5家主力机构（一般法人4家，信托公司1家），持仓量总计13038.76万股，占流通A股41.97%
其中，基金持仓与2024-12-31相比：
增仓：0家，增持 0万股
减仓：0家，减持 0万股
新出现在主力名单中：0家，持有万股
从主力名单中消失：3家，原持有6.86万股

消息面诊股

诊断结果：6.1消息面打败了53%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	股东大会	临时股东大会	2026-01-27
一般消息	重大事项	关联交易	2026-01-27
利好	业绩预告	预计扭亏	2026-01-23
一般消息	募资投向	公司购买资产	2026-01-23
一般消息	高管变动	因个人原因	2025-12-26
一般消息	重大事项	关联交易	2025-11-21
一般消息	重大事项	公司股东股份冻结	2025-08-29
一般消息	分红转增	不分配不转增	2025-08-28
一般消息	高管变动	取消监事会	2025-08-06
一般消息	高管变动	因个人原因	2025-06-18
利空	上市变动	特别处理*ST	2025-04-30
一般消息	分红转增	不分配不转增	2025-04-29

一年消息统计

	所有消息	重大消息	非重大消息
利好	1条	0条	1条
利空	1条	0条	1条

行业面诊股

诊断结果：5.9行业面打败了71%的股票医疗服务行业最新资金流向

近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，跑输大盘。

[{"date":"2026.04.27","price":"0.37","value":"-0.06"},{"date":"2026.04.24","price":"-0.69","value":"0.07"},{"date":"2026.04.23","price":"-0.88","value":"-1.89"},{"date":"2026.04.22","price":"1.30","value":"1.12"},{"date":"2026.04.21","price":"0.10","value":"-1.11"},{"date":"2026.04.20","price":"0.55","value":"0.69"},{"date":"2026.04.17","price":"0.60","value":"-1.80"},{"date":"2026.04.16","price":"2.05","value":"-0.04"},{"date":"2026.04.15","price":"-0.97","value":"0.14"},{"date":"2026.04.14","price":"1.61","value":"1.73"},{"date":"2026.04.13","price":"0.69","value":"-1.22"},{"date":"2026.04.10","price":"2.24","value":"0.70"},{"date":"2026.04.09","price":"-0.33","value":"-1.86"},{"date":"2026.04.08","price":"4.79","value":"2.51"},{"date":"2026.04.07","price":"0.36","value":"0.66"},{"date":"2026.04.03","price":"-0.99","value":"-3.06"},{"date":"2026.04.02","price":"-1.60","value":"-0.64"},{"date":"2026.04.01","price":"1.70","value":"5.25"},{"date":"2026.03.31","price":"-1.81","value":"0.22"},{"date":"2026.03.30","price":"-0.25","value":"1.19"},{"date":"2026.03.27","price":"1.13","value":"4.12"}]

深证成指,医疗服务行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	药康生物	33.29%	2.58%	6.5分
2	普瑞眼科	24.59%	8.42%	6.7分
3	昭衍新药	23.12%	-1.14%	5.5分
4	凯莱英	17.84%	3.52%	5.5分
5	美迪西	16.35%	0.13%	6.4分
6	泓博医药	16.26%	4.46%	5.6分
7	爱尔眼科	13.33%	12.51%	5.9分
8	百诚医药	12.01%	2.24%	5.9分
9	奥浦迈	11.68%	-9.94%	5.1分
10	康龙化成	10.97%	-4.12%	4.8分
11	博济医药	10.73%	4.17%	5.5分
12	金域医学	9.56%	1.95%	6.1分
13	诺思格	9.40%	-0.95%	6.3分
14	药石科技	8.34%	0.10%	5.3分
15	益诺思	7.44%	5.35%	6.0分
16	成都先导	6.87%	-0.97%	5.8分
17	泰格医药	6.38%	-3.09%	6.7分
18	百奥赛图	6.26%	0.81%	6.7分
19	华厦眼科	5.70%	3.55%	6.3分
20	诺禾致源	5.58%	0.62%	5.6分
21	博腾股份	4.90%	-2.77%	4.9分
22	皓元医药	4.58%	-6.20%	5.2分
23	药明康德	3.63%	0.76%	6.1分
24	华大基因	2.97%	2.13%	5.1分
25	迪安诊断	2.43%	-3.12%	5.7分
26	何氏眼科	2.41%	4.01%	6.3分
27	华康洁净	2.35%	-3.17%	4.9分
28	睿智医药	2.24%	-6.08%	5.1分
29	通策医疗	1.79%	3.92%	6.1分
30	万邦医药	1.69%	-5.15%	4.6分
31	和元生物	1.62%	-3.36%	4.6分
32	毕得医药	0.73%	-9.12%	4.9分
33	南模生物	0.46%	-4.64%	5.4分
34	普蕊斯	0.18%	-3.19%	5.3分
35	ST中珠	-0.36%	-6.16%	4.1分
36	*ST生物	-2.88%	1.56%	5.0分
37	三博脑科	-3.14%	-6.83%	4.2分
38	大东方	-3.53%	0.00%	4.6分
39	兰卫医学	-4.61%	-2.96%	5.4分
40	光正眼科	-4.72%	3.67%	6.1分
41	贝瑞基因	-5.28%	-3.62%	5.0分
42	-	-5.46%	-12.30%	分
43	皓宸医疗	-6.16%	1.57%	4.8分
44	百花医药	-6.60%	-5.67%	4.4分
45	创新医疗	-7.17%	-9.76%	4.7分
46	大湖股份	-7.23%	-3.90%	5.0分
47	澳洋健康	-7.60%	-1.57%	5.7分
48	海特生物	-7.60%	5.78%	5.6分
49	美年健康	-8.30%	-3.71%	5.5分
50	盈康生命	-9.18%	-5.48%	5.1分
51	新里程	-10.08%	-1.69%	5.4分
52	阳光诺和	-10.45%	-8.09%	4.6分
53	国际医学	-10.83%	-0.65%	4.7分
54	诚达药业	-13.08%	-4.41%	4.2分
55	金凯生科	-14.35%	-17.45%	4.4分
56	九洲药业	-15.49%	-17.33%	4.6分

<上一页 1 2 3 4 5...10 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
东兴证券	2012-08-29	增持	-
信达证券	2012-08-28	增持	增持
华宝证券	2012-08-18	增持	-

基本面诊股

诊断结果：6.1基本面打败了59%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，暂时未获得多数机构的显著认同，后续可继续关注。

个股深一度

潜在高分红能力：弱（32.5分）

基本面得分最高的股票

[ 截止日期：2025-09-30 ]公司经营

盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 30/103 ， 3/103。

[{"date":"2025-09-30","value":"2.18","vol":"3.24"},{"date":"2025-06-30","value":"-1.48","vol":"2.24"},{"date":"2025-03-31","value":"-0.94","vol":"0.88"},{"date":"2024-12-31","value":"-8.03","vol":"-0.21"},{"date":"2024-09-30","value":"-3.33","vol":"2.63"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净资产收益率(%)	2.18	-1.48	-0.94	-8.03	-3.33
行业(%)	3.24	2.24	0.88	-0.21	2.63

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"63.43","vol":"36.06"},{"date":"2025-06-30","value":"63.95","vol":"36.21"},{"date":"2025-03-31","value":"64.96","vol":"35.05"},{"date":"2024-12-31","value":"67.42","vol":"34.98"},{"date":"2024-09-30","value":"68.03","vol":"32.75"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
销售毛利率(%)	63.43	63.95	64.96	67.42	68.03
行业(%)	36.06	36.21	35.05	34.98	32.75

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 43/103 ， 8/103。

[{"date":"2025-09-30","value":"-9.72","vol":"3.06"},{"date":"2025-06-30","value":"-8.40","vol":"2.87"},{"date":"2025-03-31","value":"-13.55","vol":"-0.73"},{"date":"2024-12-31","value":"-1.71","vol":"-0.20"},{"date":"2024-09-30","value":"-11.78","vol":"0.86"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
营业收入同比增长率(%)	-9.72	-8.40	-13.55	-1.71	-11.78
行业(%)	3.06	2.87	-0.73	-0.20	0.86

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"162.21","vol":"20.05"},{"date":"2025-06-30","value":"58.48","vol":"-63.31"},{"date":"2025-03-31","value":"19.92","vol":"-22.07"},{"date":"2024-12-31","value":"29.56","vol":"-105.42"},{"date":"2024-09-30","value":"-1828.05","vol":"-330.42"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净利润同比增长率(%)	162.21	58.48	19.92	29.56	-1828.05
行业(%)	20.05	-63.31	-22.07	-105.42	-330.42

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 51/103 ， 52/103。

[{"date":"2025-09-30","value":"0.12","vol":"0.32"},{"date":"2025-06-30","value":"0.09","vol":"0.21"},{"date":"2025-03-31","value":"0.04","vol":"0.10"},{"date":"2024-12-31","value":"0.19","vol":"0.42"},{"date":"2024-09-30","value":"0.14","vol":"0.31"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
总资产周转率(次)	0.12	0.09	0.04	0.19	0.14
行业(次)	0.32	0.21	0.10	0.42	0.31

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"0.76","vol":"10.95"},{"date":"2025-06-30","value":"0.71","vol":"7.15"},{"date":"2025-03-31","value":"0.28","vol":"3.62"},{"date":"2024-12-31","value":"1.96","vol":"15.73"},{"date":"2024-09-30","value":"1.95","vol":"11.90"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
存货增长率(次)	0.76	0.71	0.28	1.96	1.95
行业(次)	10.95	7.15	3.62	15.73	11.90

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2025-09-30","value":"63.70","vol":"16.52"},{"date":"2025-06-30","value":"-7.33","vol":"16.38"},{"date":"2025-03-31","value":"-3.68","vol":"-0.79"},{"date":"2024-12-31","value":"-5.05","vol":"22.16"},{"date":"2024-09-30","value":"14.04","vol":"13.17"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
现金流量净额/营业收入	63.70	-7.33	-3.68	-5.05	14.04
行业	16.52	16.38	-0.79	22.16	13.17

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"0.07","vol":"0.91"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.02","vol":"1.25"},{"date":"2024-09-30","value":"","vol":"0.00"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资本支出／折旧和摊销	-	0.07	-	1.02	-
行业	0.01	0.91	0.00	1.25	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 19/103 ， 5/103。

[{"date":"2025-09-30","value":"1.42","vol":"3.67"},{"date":"2025-06-30","value":"1.58","vol":"3.57"},{"date":"2025-03-31","value":"1.28","vol":"3.68"},{"date":"2024-12-31","value":"1.32","vol":"3.58"},{"date":"2024-09-30","value":"1.83","vol":"4.11"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
流动比率	1.42	1.58	1.28	1.32	1.83
行业	3.67	3.57	3.68	3.58	4.11

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"1.18","vol":"2.94"},{"date":"2025-06-30","value":"1.46","vol":"2.87"},{"date":"2025-03-31","value":"1.03","vol":"2.97"},{"date":"2024-12-31","value":"1.15","vol":"2.89"},{"date":"2024-09-30","value":"1.70","vol":"3.45"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
速动比率	1.18	1.46	1.03	1.15	1.70
行业	2.94	2.87	2.97	2.89	3.45

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 7/103 ， 6/103。

[{"date":"2025-09-30","value":"56.93","vol":"32.60"},{"date":"2025-06-30","value":"55.01","vol":"33.58"},{"date":"2025-03-31","value":"54.27","vol":"32.05"},{"date":"2024-12-31","value":"53.63","vol":"33.31"},{"date":"2024-09-30","value":"49.30","vol":"31.15"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资产负债率(%)	56.93	55.01	54.27	53.63	49.30
行业(%)	32.60	33.58	32.05	33.31	31.15

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"1.98","vol":"0.92"},{"date":"2025-06-30","value":"1.40","vol":"0.96"},{"date":"2025-03-31","value":"1.39","vol":"0.96"},{"date":"2024-12-31","value":"1.38","vol":"1.03"},{"date":"2024-09-30","value":"1.18","vol":"1.08"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
产权比率 (%)	1.98	1.40	1.39	1.38	1.18
行业(%)	0.92	0.96	0.96	1.03	1.08

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构对该股票关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无数据

机构预测

暂时还没有机构预测该股2025年的收益，请投资者后续关注。

[{"date":"2021","yellowRectValue":"-0.19","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"-0.12","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-0.28","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-0.20","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]

[*ST生物]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]